financetom
Business
financetom
/
Business
/
Luokung Technology Gets Nasdaq Delisting Notice
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Luokung Technology Gets Nasdaq Delisting Notice
Feb 14, 2025 2:18 PM

05:01 PM EST, 02/14/2025 (MT Newswires) -- Luokung Technology ( LKCO ) said Friday it received a letter from Nasdaq after the exchange determined the company didn't provide a plan showing its ability to achieve near-term compliance with rules including minimum stockholder equity.

Nasdaq decided to deny Luokung's ( LKCO ) request for continued listing, and the company has until Feb. 18 to request an appeal of the decision.

The company said it plans to request a hearing to appeal the delisting decision before that date.

Luokung ( LKCO ) also said it's "considering all potential options available" to regain compliance with the listing rules.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FedEx forecasts fiscal 2025 profit slightly above estimates on cost cuts
FedEx forecasts fiscal 2025 profit slightly above estimates on cost cuts
Jun 25, 2024
June 25 (Reuters) - FedEx ( FDX ) forecast 2025 profit above analysts' estimates on Tuesday, anticipating that the cost reductions planned for the year would deliver margin gains, even as revenue remains challenged by lackluster demand for parcel shipping. The parcel delivery firm expects fiscal 2025 earnings per share to be in the range of $20.00 to $22.00, the...
--FedEx Guides For FY 2025 Low-to-Mid Single-Digit Percent Revenue Growth Year-Over-Year
--FedEx Guides For FY 2025 Low-to-Mid Single-Digit Percent Revenue Growth Year-Over-Year
Jun 25, 2024
04:07 PM EDT, 06/25/2024 (MT Newswires) -- Price: 279.00, Change: +22.54, Percent Change: +8.79 ...
Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing
Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing
Jun 25, 2024
04:13 PM EDT, 06/25/2024 (MT Newswires) -- Debra Durso-Bumpus, Chief People Officer, on June 21, 2024, sold 74,034 shares in Blueprint Medicines ( BPMC ) for $7,713,537. Following the Form 4 filing with the SEC, Durso-Bumpus has control over a total of 43,763 shares of the company, with 43,763 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1597264/000141588924018118/xslF345X03/form4-06252024_040601.xml ...
Liberty Latin America Insider Bought Shares Worth $3,577,620, According to a Recent SEC Filing
Liberty Latin America Insider Bought Shares Worth $3,577,620, According to a Recent SEC Filing
Jun 25, 2024
04:09 PM EDT, 06/25/2024 (MT Newswires) -- Brendan J Paddick, Director, on June 21, 2024, executed a purchase for 400,000 shares in Liberty Latin America ( LILA ) for $3,577,620. Following the Form 4 filing with the SEC, Paddick has control over a total of 1,036,108 shares of the company, with 1,036,108 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1712184/000171218424000175/xslF345X03/wk-form4_1719345823.xml Price: 9.42,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved